Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin ImmunoconjugateEric L. Sievers, Irwin D. Bernstein, Kathleen Shannon‐Dorcy et al.|Blood|1999Cited by 456
Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin ImmunoconjugateEric L. Sievers, Irwin D. Bernstein, Frederick R. Appelbaum et al.|Blood|1999Cited by 439
Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host DiseaseBadri Modi, Ryotaro Nakamura, Stephen J. Forman et al.|Biology of Blood and Marrow Transplantation|2018Cited by 84